Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Starquest Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 61
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 2
Rounds per year 10.17
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Food and Beverage
  • Sales
  • E-Commerce
  • Medical Device
  • Health Diagnostics
Summary

Starquest Capital is the famous VC, which was founded in 2008. The venture was found in Europe in France. The main office of represented VC is situated in the Paris.

We also calculated 3 valuable employees in our database.

The top activity for fund was in 2016. The fund is generally included in 2-6 deals every year. The common things for fund are deals in the range of 1 - 5 millions dollars. Opposing the other organizations, this Starquest Capital works on 27 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 4 percentage points less often commits exit comparing to other organizations.

For fund there is a match between the location of its establishment and the land of its numerous investments - France. We can highlight the next thriving fund investment areas, such as Energy, Biotechnology. The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Happydemics, Elistair, Aqylon.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Starquest Capital, startups are often financed by Innovacom, Wilco, Kima Ventures. The meaningful sponsors for the fund in investment in the same round are Bpifrance, Paca Investissement, Innovacom. In the next rounds fund is usually obtained by Bpifrance, Safran Corporate Ventures, Innovacom.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aura Group Central, Central Region, Singapore
Ballentine Capital Partners -
Blue Mountain California, San Diego, United States
Chetrit Ventures New York, New York, United States
Dcode District of Columbia, United States, Washington
Florida Angel Nexus Florida, Orlando, United States
lancers Inc Japan, Tokyo
Makuake Chiyoda, Japan
Neptune Investment Management City of London, England, United Kingdom
Normandie Business Angels Caen, France, Normandy
PM & Partners Italy, Lombardy, Milan
Quorum Group Canada, Ontario, Toronto
SamStella New York, New York, United States
Shenzhen Yuexiang Capital Management China, Futian, Guangdong
Shinnippon-hoki Publishing Aichi Prefecture, Japan, Nagoya
Steps Ventures Israel, Tel Aviv, Tel Aviv District
The Chartered Group Central, Central Region, Singapore
Vanguard Atlantic New York, Saranac Lake, United States
Yunzhong Shucheng China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Hippo T&C

Health Care
Health Diagnostics
Medical Device
Therapeutics
$2M07 Jan 2022 Suwon, Ch'ungch'ong-namdo, South Korea

Dingdong Maicai

E-Commerce
Food and Beverage
Sales
25 Jul 2019 Shanghai
News
Elistair, The Pioneer in Tethered UAVs, Announces a €5M Series B Round to Accelerate Its International Expansion

– Elistair, a market leader in tethered drones, has raised €5M from Omnes and Starquest Capital, its historic investor.
– This Series B round follows an initial €2M funding round in 2018.
– Elistair counts national security and defense organizations amongst its customers, offering them two patented product ranges: an automated tethered drone: Orion 2 and tether stations capable of transforming free-flying drones into tethered drones.
– The Orion 2 drone acts as an aerial reconnaissance mast, substantially increasing the field of vision of operating forces and reducing vulnerable entry points.
– They are also used to deploy tactical communication networks, greatly increasing the range and coverage of military radios.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Starquest Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 61
Average round size 1M
Rounds per year 10.17
Peak activity year 2014
Lead investments 5
Follow on index 0.11
Group Appearance index 0.59

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Hippo T&C

Health Care
Health Diagnostics
Medical Device
Therapeutics
$2M07 Jan 2022 Suwon, Ch'ungch'ong-namdo, South Korea

Dingdong Maicai

E-Commerce
Food and Beverage
Sales
25 Jul 2019 Shanghai
Crunchbase icon

Content report

The following text will be sent to our editors: